ADRB2 and ovarian carcinoma: NE activates the cAMP-PKC-CREB signaling pathway through ADRB2 to induce the expression of the MKP-1 gene, which inhibits the responsiveness of ovarian cancer cells to paclitaxel chemotherapy (Wu et al., 2005; Kang et al., 2016).